Organizations

Tempus AI

Organization · Company · US · 2 items since Aug 2026

Deals & regulation

  1. Sep 28

    Cleared by U.S. Food and Drug Administration

  2. Aug 24

    Cleared by U.S. Food and Drug Administration

Models & products

Products
Tempus ECG-MRTempus ECG-PH

Items

  1. Sep 28

    FDA clears Tempus ECG-MR

    The FDA granted 510(k) clearance to an AI product that analyzes standard 12-lead ECGs to flag signs of undiagnosed moderate or severe mitral regurgitation in at-risk patients 65 and older, as an early-detection referral tool.

  2. Aug 24

    FDA clears Tempus ECG-PH

    The FDA cleared AI software that reads standard 12-lead ECGs for signs of pulmonary hypertension, an assistive binary readout aimed at earlier detection of a historically underdiagnosed condition and Tempus's third cleared cardiovascular device.